These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20848681)

  • 1. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Ruffolo C; Scarpa M; Bassi N
    N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
    N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Herrlinger KR; Stange EF
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Gelber AC
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic impact of combination therapy with infliximab plus azathioprine for drug-refractory Crohn's disease: a cost-effectiveness analysis.
    Saito S; Shimizu U; Nan Z; Mandai N; Yokoyama J; Terajima K; Akazawa K
    J Crohns Colitis; 2013 Mar; 7(2):167-74. PubMed ID: 22626508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
    van den Brande JM; Peppelenbosch MP; Hommes DW
    Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
    [No Abstract]   [Full Text] [Related]  

  • 8. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
    Abou Zahr A; Saad Aldin E; Yunyongying P
    Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
    Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
    Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 11. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease.
    Marchetti M; Liberato NL; Di Sabatino A; Corazza GR
    Eur J Health Econ; 2013 Dec; 14(6):853-61. PubMed ID: 22975794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
    Chen SC; Cummings OW; Hartley MP; Filomena CA; Cho WK
    Dig Dis Sci; 2006 May; 51(5):952-5. PubMed ID: 16670938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 16. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and azathioprine: bridge or parachute?
    Travis S
    Gastroenterology; 2006 Apr; 130(4):1354-7. PubMed ID: 16618428
    [No Abstract]   [Full Text] [Related]  

  • 18. Early combined immunosuppression in Crohn's disease.
    Badina L; Taddio A; Ventura A
    Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
    [No Abstract]   [Full Text] [Related]  

  • 19. Early combined immunosuppression in Crohn's disease.
    Lees CW; Satsangi J
    Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555905
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)].
    Fölsch UR; Nitschmann S
    Internist (Berl); 2010 Sep; 51(9):1202-4. PubMed ID: 20658120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.